AGE-RAGE signal generates a specific NF-Κ B RelA "barcode" that directs collagen i expression

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Peng, Yunqian ^a   Kim, Ji Min ^a   Park, Hal Sol ^a   Yang, Annie ^a   Islam, Celia ^a   Lakatta, Edward G ^a   Lin, Li ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA 2(I) COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; PROTEIN BINDING; TRANSCRIPTION FACTOR RELA;

ANIMAL; CHROMATIN IMMUNOPRECIPITATION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; HIGH THROUGHPUT SEQUENCING; MACROPHAGE; METABOLISM; MOUSE; MUTATION; PROTEIN PROCESSING; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; CHROMATIN IMMUNOPRECIPITATION; COLLAGEN TYPE I; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GLYCOSYLATION END PRODUCTS, ADVANCED; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MUTATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; REGULATORY SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84953333439     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18822     Document Type: Article

References (61)

1. Ott, C. et al. Role of advanced glycation end products in cellular signaling. Redox Biol 2, 411-429 (2014).
2. Semba, R. D., Nicklett, E. J., Ferrucci, L. Does accumulation of advanced glycation end products contribute to the aging phenotype J Gerontol A Biol Sci Med Sci 65, 963-975 (2010).
3. Brownlee, M. The pathological implications of protein glycation. Clin Invest Med 18, 275-281 (1995).
4. Yan, S. F., Ramasamy, R., Schmidt, A. M. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106, 842-853 (2010).
5. Ibrahim, Z. A., Armour, C. L., Phipps, S., Sukkar, M. B. RAGE and TLRs: relatives, friends or neighbours Mol Immunol 56, 739-744 (2013).
6. Lin, L. RAGE on the Toll RoadCell Mol Immunol 3, 351-358 (2006).
7. Yamamoto, Y. et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol 186, 3248-3257 (2011).
8. Sakaguchi, M. et al. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 6, e23132 (2011).
9. Hayden, M. S., Ghosh, S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26, 203-234 (2012).
10. Huang, B., Yang, X. D., Lamb, A., Chen, L. F. Posttranslational modifications of NF-kappaB: another layer of regulation for NFkappaB signaling pathway. Cell Signal 22, 1282-1290 (2010).
11. Perkins, N. D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25, 6717-6730 (2006).
12. Hochrainer, K., Racchumi, G., Anrather, J. Site-specific phosphorylation of the p65 protein subunit mediates selective gene expression by differential NF-kappaB and RNA polymerase II promoter recruitment. J Biol Chem 288, 285-293 (2013).
13. Hayden, M. S., Ghosh, S. Shared principles in NF-kappaB signaling. Cell 132, 344-362 (2008).
14. Moreno, R., Sobotzik, J. M., Schultz, C., Schmitz, M. L. Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res 38, 6029-6044 (2010).
15. Ishinaga, H. et al. TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. EMBO J 26, 1150-1162 (2007).
16. Lakatta, E. G. The reality of aging viewed from the arterial wall. Artery Res 7, 73-80 (2013).
17. Sawabe, M. Vascular aging: from molecular mechanism to clinical significance. Geriatr Gerontol Int 10 Suppl 1, S213-220 (2010).
18. Zieman, S. J., Melenovsky, V., Kass, D. A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25, 932-943 (2005).
19. Brett, J. et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143, 1699-1712 (1993).
20. Yamamoto, Y. et al. Roles of the AGE-RAGE system in vascular injury in diabetes. Ann N Y Acad Sci 902, 163-170; discussion 170-162 (2000).
21. Barnes, M. J., Farndale, R. W. Collagens and atherosclerosis. Exp Gerontol 34, 513-525 (1999).
22. Grozinger, G. et al. Decreased neointimal extracellular matrix formation in RAGE-knockout mice after microvascular denudation. Cardiovasc Intervent Radiol 35, 1439-1447 (2012).
23. Daily, K., Patel, V. R., Rigor, P., Xie, X., Baldi, P. MotifMap: integrative genome-wide maps of regulatory motif sites for model species. BMC Bioinformatics 12, 495 (2011).
24. Wang, R., Kudo, M., Yokoyama, M., Asano, G. Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. J Nippon Med Sch 68, 472-481 (2001).
25. Arumugam, T., Simeone, D. M., Schmidt, A. M., Logsdon, C. D. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279, 5059-5065 (2004).
26. Bohuslav, J., Chen, L. F., Kwon, H., Mu, Y., Greene, W. C. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 279, 26115-26125 (2004).
27. Buss, H. et al. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279, 55633-55643 (2004).
28. Buss, H. et al. Cyclin-dependent kinase 6 phosphorylates NF-kappaB P65 at serine 536 and contributes to the regulation of inflammatory gene expression. PLoS One 7, e51847 (2012).
29. Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., Karin, M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005).
30. Wang, Y., Xiang, G. S., Kourouma, F., Umar, S. Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation. Br J Pharmacol 148, 814-824 (2006).
31. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., Kasaoka, T. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 550, 107-113 (2003).
32. Xu, D., Kyriakis, J. M. Phosphatidylinositol 3-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J Biol Chem 278, 39349-39355 (2003).
33. Roux, P. P., Richards, S. A., Blenis, J. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol Cell Biol 23, 4796-4804 (2003).
34. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92, 7686-7689 (1995).
35. Sapkota, G. P. et al. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J 401, 29-38 (2007).
36. Duran, A., Diaz-Meco, M. T., Moscat, J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22, 3910-3918 (2003).
37. Romanelli, A., Martin, K. A., Toker, A., Blenis, J. p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol Cell Biol 19, 2921-2928 (1999).
38. Ryo, A. et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12, 1413-1426 (2003).
39. Al Rifai, M. et al. sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Diabetes Complications 29, 180-185 (2015).
40. Grossin, N. et al. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol Nutr Food Res 59, 927-938 (2015).
41. Ramasamy, R. et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16R-28R (2005).
42. Hattori, Y., Suzuki, M., Hattori, S., Kasai, K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 39, 22-28 (2002).
43. Kislinger, T. et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274, 31740-31749 (1999).
44. Lin, L., Park, S., Lakatta, E. G. RAGE signaling in inflammation and arterial aging. Front Biosci (Landmark Ed) 14, 1403-1413 (2009).
45. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Van Obberghen, E. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem 276, 43836-43841 (2001).
46. Yan, S. D. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269, 9889-9897 (1994).
47. Beauchef, G. et al. The p65 subunit of NF-kappaB inhibits col1a1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3). J Biol Chem 287, 3462-3478 (2012).
48. Owen, W. F., Jr. et al. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Kidney Int 53, 1365-1373 (1998).
49. Rippe, R. A., Schrum, L. W., Stefanovic, B., Solis-Herruzo, J. A., Brenner, D. A. NF-kappaB inhibits expression of the alpha1(I) collagen gene. DNA Cell Biol 18, 751-761 (1999).
50. Solis-Herruzo, J. A., Brenner, D. A., Chojkier, M. Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem 263, 5841-5845 (1988).
51. Szoka, L., Karna, E., Palka, J. A. UVC inhibits collagen biosynthesis through up-regulation of NF-kappaB p65 signaling in cultured fibroblasts. J Photochem Photobiol B 129, 143-148 (2013).
52. Buttner, C., Skupin, A., Rieber, E. P. Transcriptional activation of the type I collagen genes col1a1 and col1a2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol 198, 248-258 (2004).
53. Huang, J. S. et al. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 81, 102-113 (2001).
54. Makino, S. et al. DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts. J Dermatol Sci 51, 171-180 (2008).
55. Tang, J. B., Xu, Y., Ding, F., Wang, X. T. Expression of genes for collagen production and NF-kappaB gene activation of in vivo healing flexor tendons. J Hand Surg Am 29, 564-570 (2004).
56. Heintzman, N. D., Ren, B. Finding distal regulatory elements in the human genome. Curr Opin Genet Dev 19, 541-549 (2009).
57. Mielke, C. et al. Multiple collagen I gene regulatory elements have sites of stress-induced DNA duplex destabilization and nuclear scaffold/matrix association potential. J Cell Biochem 84, 484-496 (2002).
58. Mahali, S. K., Verma, N., Manna, S. K. Advanced glycation end products induce lipogenesis: regulation by natural xanthone through inhibition of ERK and NF-kappaB. J Cell Physiol 229, 1972-1980 (2014).
59. Jozefczuk, J., Drews, K., Adjaye, J. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J Vis Exp, doi: 10.3791/3854 (2012).
60. Zhang, X., Goncalves, R., Mosser, D. M. The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14, Unit 14 11 (2008).
61. Schmittgen, T. D., Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101-1108 (2008).